
|Articles|February 6, 2020
PPD Goes Public
Advertisement
Last month, PPD announced its plans to go public-the second time in its existence-filing its IPO for stock in January. Today, it began trading as PPD at $27 a share on the NASDAQ. PPD was founded in 1985 by Fred Eshelman, who took the company public in 1996. In 2011, it went private again with its
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement